Mckesson Corporation
One of the world's largest healthcare companies, McKesson distributes branded, generic, specialty, and over-the-counter drugs to retail chains, community pharmacies, hospitals, and clinics across the U.S. and Canada, and supplies medical-surgical products to doctors' offices and other non-acute care settings. It began in 1833 in New York City as Olcott & McKesson, a drug import business founded by John McKesson and Charles Olcott, becoming McKesson & Robbins in 1853 when apprentice-turned-partner Daniel Robbins joined. Fun fact: the name "Robbins" comes from that early partner, and the company once made its own consumer medicines such as cough syrup and Epsom salts.
Granted 176.2K · Sold 107.0K
Granted 477.9K · Sold 373.7K
Granted 4.2K
Granted 18.4K · Sold 7.7K
Granted 7.6K · Sold 5.4K
Granted 11.9K · Sold 7.7K
Granted 163.2K · Sold 142.4K
Granted 16.1K · Sold 6.9K
Granted 36.4K · Sold 22.8K
Granted 773
Granted 32.4K · Sold 32.8K
Granted 650
Granted 6.1K · Sold 3.0K
Granted 483
Granted 1.1K · Sold 832
Granted 301
Granted 301
Granted 606 · Sold 610.98
Sold 34
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Vitalone Britt J.EVP & CFO · 76 transactions | -0.3% | 22.5K | 176.2K | — | 107.0K |
| Tyler Brian S.Chief Executive Officer, Director · 134 transactions | -44.5% | 14.6K | 477.9K | — | 373.7K |
| Fraga FranciscoEVP, CIO and CTO · 10 transactions | — | 6.3K | 4.2K | — | — |
| Smith LeAnn BEVP & Chief HR Officer · 58 transactions | — | 4.8K | 18.4K | — | 7.7K |
| Flores NancyEVP, CIO & CTO · 9 transactions | -1.6% | 4.7Kas of May 2022 | 7.6K | — | 5.4K |
| Avila NancyEVP, CIO & CTO · 12 transactions | — | 4.6Kas of May 2023 | 11.9K | — | 7.7K |
| Schechter Lori A.EVP, Chief Legal Officer & GC · 41 transactions | -77.2% | 4.4Kas of Jun 2023 | 163.2K | — | 142.4K |
| Lau MicheleEVP and Chief Legal Officer · 20 transactions | — | 3.4K | 16.1K | — | 6.9K |
| Rodgers Thomas LEVP, Chief Strategy & BDO · 59 transactions | +95.3% | 2.3K | 36.4K | — | 22.8K |
| Knauss Donald RDirector · 2 transactions | +59.6% | 2.1Kas of Jul 2023 | 773 | — | — |
| Faber TracyEVP & Chief HR Officer · 43 transactions | -72.6% | 1.9Kas of Nov 2022 | 32.4K | — | 32.8K |
| Caruso Dominic JDirector · 2 transactions | — | 650as of Jul 2025 | 650 | — | — |
| Rutledge Napoleon B JRSVP, Controller & CAO · 41 transactions | — | 632 | 6.1K | — | 3.0K |
| Mantia Linda ProvieDirector · 1 transaction | — | 483as of Jul 2023 | 483 | — | — |
| Martinez MariaDirector · 5 transactions | — | 301 | 1.1K | — | 832 |
| Lerman Bradley EDirector · 1 transaction | — | 301as of Jul 2025 | 301 | — | — |
| Wilson-Thompson KathleenDirector · 1 transaction | — | 301as of Jul 2025 | 301 | — | — |
| Salka Susan RDirector · 6 transactions | — | 0.98as of May 2024 | 606 | — | 610.98 |
| Emerson KevinSVP, Controller & CAO · 2 transactions | — | 0.28as of Feb 2022 | — | — | 34 |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -710.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.